Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Pentostatin | hsa00220 | Arginine biosynthesis | 2.66E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Pentostatin | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Pentostatin | hsa04012 | ErbB signaling pathway | 4.91E-02 | 3 | P49841, Q13191, P42338 | GSK3B, CBLB, PIK3CB | More | | Pentostatin | hsa04060 | Cytokine-cytokine receptor interaction | 3.84E-02 | 8 | P14784, P27930, Q13651, Q9HBE5, P25024, P01375, P09341, Q93038 | IL2RB, IL1R2, IL10RA, IL21R, CXCR1, TNF, CXCL1, TNFRSF25 | More | | Pentostatin | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.44E-02 | 5 | P09341, P25024, Q13651, P14784, P01375 | CXCL1, CXCR1, IL10RA, IL2RB, TNF | More | | Pentostatin | hsa04064 | NF-kappa B signaling pathway | 3.38E-02 | 6 | O00463, P01375, Q04759, Q16548, P06239, P09341 | TRAF5, TNF, PRKCQ, BCL2A1, LCK, CXCL1 | More | | Pentostatin | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Pentostatin | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | | Pentostatin | hsa04612 | Antigen processing and presentation | 3.06E-02 | 5 | P13765, P26715, P26717, P01732, P01375 | HLA-DOB, KLRC1, KLRC2, CD8A, TNF | More | | Pentostatin | hsa04640 | Hematopoietic cell lineage | 5.76E-03 | 7 | P27930, P25063, P07766, P01732, P09564, P13765, P01375 | IL1R2, CD24, CD3E, CD8A, CD7, HLA-DOB, TNF | More | | Pentostatin | hsa04650 | Natural killer cell mediated cytotoxicity | 8.56E-04 | 8 | P01375, P06239, O60880, P20963, P42338, P26718, P26717, P26715 | TNF, LCK, SH2D1A, CD247, PIK3CB, KLRK1, KLRC2, KLRC1 | More | | Pentostatin | hsa04658 | Th1 and Th2 cell differentiation | 6.68E-06 | 9 | Q04759, P07766, P20963, P06239, Q14765, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, LCK, STAT4, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Pentostatin | hsa04659 | Th17 cell differentiation | 4.19E-04 | 8 | Q04759, P06239, P14784, P13765, Q9HBE5, Q9UL17, P07766, P20963 | PRKCQ, LCK, IL2RB, HLA-DOB, IL21R, TBX21, CD3E, CD247 | More | | Pentostatin | hsa04660 | T cell receptor signaling pathway | 2.88E-05 | 10 | P01375, Q04759, P42338, Q08881, P07766, P20963, P01732, Q13191, P06239, P49841 | TNF, PRKCQ, PIK3CB, ITK, CD3E, CD247, CD8A, CBLB, LCK, GSK3B | More | | Pentostatin | hsa04668 | TNF signaling pathway | 3.06E-02 | 5 | P01375, O00463, P09341, P20749, P42338 | TNF, TRAF5, CXCL1, BCL3, PIK3CB | More | | Pentostatin | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Pentostatin | hsa04750 | Inflammatory mediator regulation of TRP channels | 2.28E-02 | 4 | P22694, P42338, P24723, Q04759 | PRKACB, PIK3CB, PRKCH, PRKCQ | More | | Pentostatin | hsa04910 | Insulin signaling pathway | 1.08E-02 | 5 | P22694, P06737, P42338, P49841, Q13191 | PRKACB, PYGL, PIK3CB, GSK3B, CBLB | More | | Pentostatin | hsa04931 | Insulin resistance | 7.80E-03 | 5 | P01375, P42338, P49841, Q04759, P06737 | TNF, PIK3CB, GSK3B, PRKCQ, PYGL | More | | Pentostatin | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Pentostatin | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Pentostatin | hsa05135 | Yersinia infection | 1.45E-02 | 5 | P06239, P01375, P42338, P49841, P01732 | LCK, TNF, PIK3CB, GSK3B, CD8A | More | | Pentostatin | hsa05142 | Chagas disease | 3.97E-02 | 4 | P01375, P42338, P07766, P20963 | TNF, PIK3CB, CD3E, CD247 | More | | Pentostatin | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Pentostatin | hsa05144 | Malaria | 7.31E-03 | 4 | P60033, P01375, P35443, P26718 | CD81, TNF, THBS4, KLRK1 | More | | Pentostatin | hsa05146 | Amoebiasis | 6.94E-05 | 8 | P09341, P27930, P01375, P42338, P05089, P22694, P12814, P08311 | CXCL1, IL1R2, TNF, PIK3CB, ARG1, PRKACB, ACTN1, CTSG | More | | Pentostatin | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Pentostatin | hsa05163 | Human cytomegalovirus infection | 4.01E-02 | 6 | P42338, P01375, P22694, P49841, Q13651, O00463 | PIK3CB, TNF, PRKACB, GSK3B, IL10RA, TRAF5 | More | | Pentostatin | hsa05169 | Epstein-Barr virus infection | 1.54E-02 | 8 | P13765, Q13547, O00463, P42338, Q13761, P01375, P07766, P20963 | HLA-DOB, HDAC1, TRAF5, PIK3CB, RUNX3, TNF, CD3E, CD247 | More | | Pentostatin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.90E-02 | 5 | P42338, P07766, P20963, P06239, Q04759 | PIK3CB, CD3E, CD247, LCK, PRKCQ | More | | Pentostatin | hsa05310 | Asthma | 3.36E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Pentostatin | hsa05321 | Inflammatory bowel disease | 7.29E-04 | 5 | P01375, P13765, Q14765, Q9UL17, Q9HBE5 | TNF, HLA-DOB, STAT4, TBX21, IL21R | More | | Pentostatin | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Pentostatin | hsa05332 | Graft-versus-host disease | 2.07E-03 | 4 | P13765, P48023, P01375, P26715 | HLA-DOB, FASLG, TNF, KLRC1 | More | | Pentostatin | hsa05418 | Fluid shear stress and atherosclerosis | 3.77E-02 | 5 | P42338, Q14145, P10599, P01375, P27930 | PIK3CB, KEAP1, TXN, TNF, IL1R2 | More | | |